Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Medincell SA

MDCLF
Current price
6.98 USD 0 USD (0.00%)
Last closed 18.46 EUR
ISIN FR0004065605
Sector Healthcare
Industry Biotechnology
Exchange PA
Capitalization 540 735 531 EUR
Yield for 12 month +144.32 %
1Y
3Y
5Y
10Y
15Y
MDCLF
21.11.2021 - 28.11.2021

MedinCell S.A., a pharmaceutical company, develops long acting injectables in various therapeutic areas in France. It develops solutions based on BEPO, a long-acting injectable technology; and offers UZEDY (mdc-IRM) for the treatment of schizophrenia in adults. The company's products in development include mdc-CWM, a sustained-release formulation of celecoxib in Phase III trials for use in the treatment of reduction of postoperative pain and inflammation; and mdc-TJK, a subcutaneous injection that is in Phase III clinical trials for use in the treatment of schizophrenia. Its product candidates in preclinical trials include mdc-WWM for contraception; and mdc-STM for malaria. MedinCell S.A. was incorporated in 2003 and is headquartered in Jacou, France. Address: 3 rue des Frères Lumière, Jacou, France, 34830

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

18.39 EUR

P/E ratio

Dividend Yield

Current Year

+9 008 343 EUR

Last Year

+9 863 098 EUR

Current Quarter

+2 041 638 EUR

Last Quarter

+6 966 705 EUR

Current Year

+9 136 007 EUR

Last Year

+13 619 234 EUR

Current Quarter

+2 041 638 EUR

Last Quarter

+8 158 574 EUR

Key Figures MDCLF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -19 993 494 EUR
Operating Margin TTM -318.27 %
PE Ratio
Return On Assets TTM -39.49 %
PEG Ratio
Return On Equity TTM
Wall Street Target Price 18.39 EUR
Revenue TTM 11 913 713 EUR
Book Value -1.4 EUR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -36.7 %
Dividend Yield
Gross Profit TTM 13 619 234 EUR
Earnings per share -0.88 EUR
Diluted Eps TTM -0.88 EUR
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin -209.61 %

Dividend Analytics MDCLF

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History MDCLF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation MDCLF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 62.9917
Price Sales TTM 45.3877
Enterprise Value EBITDA -11.8173
Price Book MRQ 27.5888

Financials MDCLF

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators MDCLF

For 52 weeks

5.24 EUR 18.69 EUR
50 Day MA 15.61 EUR
Shares Short Prior Month
200 Day MA 11.42 EUR
Short Ratio
Shares Short
Short Percent

Dynamics of changes in the value of assets

E

EIMCOELECO

3 056.80 INR Eimco Elecon (India) Limited -0.56 (-1.51%)
Detailed analytics
C

CCC

19.25 SEK Cavotec SA -0.05 (-2.53%)
Detailed analytics
E

ELEK

0.060 USD China Xuefeng Environmental Engineering Inc +0 (+1.69%)
Detailed analytics
M

MDF

16.16 EUR Medifast Inc. 0 (0%)
Detailed analytics
D

DTV0

1.06 EUR WITHSECURE CORP. 0 (0%)
Detailed analytics